Evidence map›Paper›PMID 24837396›Full record

ArticleWomen's health issues : official publication of the Jacobs Institute of Women's Health

Women's perspectives on female-initiated barrier methods for the prevention of HIV in the context of methamphetamine use and partner violence.

Jamila K Stockman, Jennifer L Syvertsen, Angela M Robertson, Natasha T Ludwig-Barron, Julie N Bergmann, Lawrence A Palinkas

Open access · greenAbstract read
In one paragraph

Article in Women's health issues : official publication of the Jacobs Institute of Women's Health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jamila K StockmanDivision of Global Public Health, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California. Electronic address: stockman78@hotmail.com.
Jennifer L SyvertsenDepartment of Anthropology, College of Arts and Sciences, Ohio State University, Columbus, Ohio.
Angela M RobertsonDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; The Fenway Institute, Fenway Health, Boston, Massachusetts.
Natasha T Ludwig-BarronDivision of Global Public Health, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California.
Julie N BergmannDivision of Global Public Health, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California.
Lawrence A PalinkasSchool of Social Work, University of Southern California, Los Angeles, California.
University of California, San Diego · USFlorida State University · USHarvard University · USUniversity of Southern California · US

Funding

HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
Reducing HIV/STD risk, methamphetamine use, and depression among heterosexualsR01MH061146 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SEMPLE, SHIRLEY J. · 2001 to 2010
$5.1M
HIV Intervention Science Training Program for Underserved Investigators R25MH080665 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, WU, ELWIN · 2007 to 2023
$2.8M
The Impact of Environmental and Physiological Factors on Sexual Assault and HIVR01HD077891 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STOCKMAN, JAMILA KINSHASA · 2013 to 2017
$2.4M
Impact of Violence and Power on a HIV Behavioral Intervention for Female MA UsersK01DA031593 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STOCKMAN, JAMILA KINSHASA · 2011 to 2015
$897k
Center for HIV/AIDS Minority Pipeline in Substance Abuse Research (CHAMPS)R25DA025571 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2010
$784k
HIV/AIDS: Translational Approaches and Health DisparitiesR25MH080664 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WYATT, GAIL E. · 2009 to 2011
$580k
Concurrent Partnerships Among High-Risk Couples in the U.S.-Mexico Border RegionR36DA032376 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2011 to 2012
$107k
NIAID NIH HHS T32 AI007384NIAID NIH HHS T32AI007384NICHD NIH HHS R01 HD077891NICHD NIH HHS R01HD077891NIDA NIH HHS K01 DA031593NIDA NIH HHS K01DA031593NIDA NIH HHS R25 DA025571NIDA NIH HHS R25DA025571NIDA NIH HHS R36 DA032376NIDA NIH HHS R36DA032376NIDA NIH HHS T32 DA023356NIDA NIH HHS T32DA023356NIMHD NIH HHS L60 MD003701NIMHD NIH HHS L60MD003701NIMH NIH HHS R01 MH061146NIMH NIH HHS R01MH061146NIMH NIH HHS R25 MH080664NIMH NIH HHS R25MH080664NIMH NIH HHS R25 MH080665NIMH NIH HHS R25MH080665
6 · The paper itself

Abstract

backgroundFemale-initiated barrier methods for the prevention of HIV may be an effective alternative for drug-using women who are unable to negotiate safe sex, often as a result of physical and/or sexual partner violence.

methodsUtilizing a SAVA (substance abuse, violence, and AIDS) syndemic framework, we qualitatively examined perspectives on female condoms and vaginal microbicides among 18 women with histories of methamphetamine abuse and partner violence in San Diego, California.

findingsMost women were not interested in female condoms owing to perceived discomfort, difficulty of insertion, time-intensive effort, and unappealing appearance. Alternatively, most women viewed vaginal microbicides as a useful method. Positive aspects included convenience, ability to disguise as a lubricant, and a sense of control and empowerment. Concerns included possible side effects, timing of application, and unfavorable characteristics of the gel. Acceptability of female-initiated barrier methods was context dependent (i.e., partner type, level of drug use and violence that characterized the sexual relationship).

conclusionsFindings indicate that efforts are needed to address barriers identified for vaginal microbicides to increase its uptake in future HIV prevention trials and marketing of future Food and Drug Administration-approved products. Strategies should address gender-based inequalities (e.g., partner violence) experienced by drug-using women and promote female empowerment. Education on female-initiated barrier methods is also needed for women who use drugs, as well as health care providers and other professionals providing sexual health care and contraception to women with histories of drug use and partner violence.

Indexed as

Anti-Infective AgentsAttitude to HealthMethamphetamineSingle-Use Internal CondomSubstance-Related DisordersViolenceAdultCaliforniaCrime VictimsFemaleHIV InfectionsHumansMaleMiddle AgedPatient SatisfactionRisk FactorsAnti-Infective AgentsMethamphetamine

Identifiers

PMID24837396
PMCPMC4077979
OpenAlexW2130995573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.